C18 Ceramide-d3 (d18:1/18:0-d3)

C18 Ceramide-d3 (d18:1/18:0-d3) Suppliers list
Company Name: Alfa Chemistry
Tel:
Email: Info@alfa-chemistry.com
Products Intro: Product Name:C18 Ceramide-d3 (d18:1/18:0-d3)
CAS:2011762-82-4
Purity:0.99 Remarks:https://lipids.alfa-chemistry.com/product/c18-ceramide-d3-d18-1-18-0-d3-cas-2011762-82-4-318153.html
Company Name: Yichang Zhongyitai Trading Co., Ltd.  
Tel: 0717-6449896 13886658719
Email: root@zhongyitai.com
Products Intro: Product Name:C18 Ceramide-d3 (d18:1/18:0-d3)
CAS:2011762-82-4
Purity:99% Package:1mg
Company Name: Alfa Chemistry  
Tel: 1-516-6625404
Email: support@alfa-chemistry.com
Products Intro: Product Name:C18 Ceramide-d3 (d18:1/18:0-d3)
CAS:2011762-82-4
Purity:99%+ Package:1g;10g;100g;1KG;5KG
Company Name: ChemeGen(Shanghai) Biotechnology Co.,Ltd.  
Tel: 18818260767
Email: sales@chemegen.com
Products Intro: Product Name:C18 Ceramide-d3 (d18:1/18:0-d3)
CAS:2011762-82-4
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Products Intro: Product Name:C18 Ceramide-d3 (d18:1/18:0-d3)
CAS:2011762-82-4
Purity:>95% Package:1mg
C18 Ceramide-d3 (d18:1/18:0-d3) Basic information
Product Name:C18 Ceramide-d3 (d18:1/18:0-d3)
Synonyms:C18 Ceramide-d3 (d18:1/18:0-d3);N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl-d3]-octadecanamide
CAS:2011762-82-4
MF:C36H71NO3
MW:565.97
EINECS:
Product Categories:
Mol File:2011762-82-4.mol
C18 Ceramide-d3 (d18:1/18:0-d3) Structure
C18 Ceramide-d3 (d18:1/18:0-d3) Chemical Properties
storage temp. Store at -20°C
solubility Chloroform: Soluble,DMF: Soluble,Ethanol: Warmed
form A solid
Safety Information
MSDS Information
C18 Ceramide-d3 (d18:1/18:0-d3) Usage And Synthesis
Biological ActivityC18 Ceramide-d3 (d18:1/18:0) is intended for use as an internal standard for the quantification of C18 Ceramide (d18:1/18:0) by GC- or LC-MS. C18 Ceramide is an endogenous bioactive sphingolipid. It is the primary short-chain ceramide found in brain tissue whose synthesis is regulated by longevity-assurance homologue 1 (Lass1) in mice.1 Increased expression of C18 ceramide reduces cell growth in UM-SCC-22A squamous cell carcinoma cells.2 It is selectively downregulated in 32 human head and neck squamous cell carcinoma tumor tissues as compared to non-squamous tumor tissues. C18 Ceramide concentration is significantly higher in muscle tissue of type 2 diabetic patients compared with non-diabetic patients and is positively correlated to body mass index and inversely related to insulin sensitivity.3 [Matreya, LLC. Catalog No. 2201]
References1.Mizutani, Y., Kihara, A., and Igarashi, Y.Mammalian Lass6 and its related family members regulate synthesis of specific ceramidesBiochem J.390(Pt. 1)263-271(2005) 2.Koybasi, S., Senkal, C.E., Sundararaj, K., et al.Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomasJ. Biol. Chem.279(43)44311-44319(2004) 3.Bergman, B.C., Brozinick, J.T., Strauss, A., et al.Muscle sphingolipids during rest and exercise: A C18:0 signature for insulin resistance in humansDiabetologia59(3)785-791(2016)
C18 Ceramide-d3 (d18:1/18:0-d3) Preparation Products And Raw materials
Tag:C18 Ceramide-d3 (d18:1/18:0-d3)(2011762-82-4) Related Product Information